Hair loss is not a uniform process. What is happening in a 22-year-old’s follicles is biologically different from what is happening in a 45-year-old’s. The treatments that produce the most dramatic results for one age group produce diminishing returns for another.
The earlier you intervene, the more you can recover. But that does not mean later intervention is futile — it means the realistic expectations and the most effective interventions shift.
The follicles remember where they began. The question is whether you give them the signal to return.
Ages 15–19: The Early Signs
What Is Happening
Most teenagers experiencing hair loss are surprised to learn that androgenetic alopecia can begin this early. Hormonal surges at puberty activate genetic predispositions — DHT begins interacting with follicle receptors that were previously unexposed to adult-level androgen signals.
The changes at this stage are subtle: a slightly more prominent temple, a hairline that seems to sit slightly higher than photographs from a year ago, increased shedding that gets dismissed as stress. Seborrheic dermatitis and scalp inflammation are also common at this age, contributing to follicular stress.
Norwood classification at this stage is typically 1–2 — the earliest stages, with minimal recession.
What Works
First-line options without systemic intervention:
- Ketoconazole 2% shampoo: Safe, accessible, and reduces scalp inflammation and local androgen activity
- Alfatradiol 0.025% topical: A weak topical 5-alpha-reductase inhibitor with minimal systemic absorption; used in European markets
- Fluridil 2% topical: A topical androgen receptor blocker that cycles off rapidly and produces no detectable systemic effects
Dietary and lifestyle intervention: Correcting iron, zinc, and vitamin D deficiencies addresses a meaningful contributor to shedding in this age group, where growth spurts and poor dietary habits frequently combine.
Reversal potential: Very high. Follicles at this stage are still actively cycling and have not undergone significant miniaturisation. Intervention here produces the most dramatic long-term outcomes.
Ages 20–29: The Critical Window
What Is Happening
The twenties represent the most common decade for androgenetic alopecia to become undeniable. DHT-driven miniaturisation accelerates, the hairline begins a visible recession, and the vertex (crown) may start thinning. This is also the decade when the psychological impact is highest — hair loss in your twenties arrives alongside identity formation, relationships, and professional development.
Norwood 1–4 is the typical range. This is the most important intervention window. Follicles that have begun miniaturising but have not yet become dormant are most responsive to treatment. The difference between starting treatment at 23 versus 33 is often the difference between substantially recovering hair density and maintaining what you have.
What Works
Finasteride 1mg daily: The gold standard. Around 90% success rate for halting progression; approximately 65% of users see measurable regrowth. Every year of earlier treatment is a year of miniaturisation prevented.
Minoxidil 5% topical: Works synergistically with finasteride. Applied twice daily to dry scalp. Initial shedding at weeks 2–6 is expected and normal.
Microneedling + minoxidil: In controlled trials, this combination produces more than double the hair count improvement of minoxidil alone.
Tretinoin 0.01% topical compound: Rescues approximately 40% of minoxidil non-responders by upregulating scalp sulfotransferase.
Reversal potential: High. With consistent treatment beginning in the mid-twenties, most people can expect significant regrowth and long-term stabilisation. Realistic timeline: 12–24 months to see peak results.
Ages 30–39: Working with What Remains
What Is Happening
The thirties often bring a reckoning. Untreated AGA from the twenties has progressed — Norwood 3–5 is common by the mid-thirties in those who have not intervened. Diffuse thinning across the vertex accelerates. The hairline recession is now pronounced enough to affect how people style their hair and how they feel in social situations.
Lifestyle factors become increasingly relevant here: elevated cortisol from career stress, sleep disruption, and metabolic changes all interact with the existing hormonal trajectory.
What Works
Finasteride + minoxidil combination: Still the most effective non-surgical protocol. Response rates are somewhat lower than in the twenties because more follicles have undergone advanced miniaturisation, but meaningful stabilisation and partial regrowth remain achievable.
Oral minoxidil (off-label, 0.25–2.5mg): More consistently effective than topical minoxidil for people who are poor topical responders. Requires medical supervision.
Dutasteride (off-label): More potent DHT suppression than finasteride. Studies show superior hair count outcomes. Appropriate for those who have not achieved satisfactory results with finasteride at 12 months.
PRP (platelet-rich plasma) as adjunct: Not first-line, but evidence supports meaningful benefit when added to an existing pharmacological protocol.
Reversal potential: Moderate to high. Vellus-to-terminal hair conversion is achievable, particularly at the temples and crown where follicles are miniaturised but not dormant. Managing expectations appropriately: restoration to peak density is unlikely; meaningful improvement is realistic.
Ages 40–55: Managing the Long Arc
What Is Happening
Without long-term treatment, Norwood 5–6 is common by the mid-forties. The conversion rate of testosterone to DHT increases with age. Metabolic health — insulin sensitivity, thyroid function — becomes more directly relevant to hair loss progression. Scalp fibrosis may have begun in areas of severe, long-standing miniaturisation, which limits the reversibility of follicular activity in those specific regions.
The psychological burden often peaks in this decade. Men who did not treat earlier frequently arrive here with a combination of regret and the question: is it too late?
The honest answer is: not for all of it.
What Works
Finasteride: Still effective for halting progression and producing some regrowth. Results come more slowly than in younger patients.
Oral minoxidil (5mg under medical supervision): Particularly effective for diffuse thinning at this age. Requires cardiac history consideration.
Hair transplant (FUE/FUT): A viable, permanent option for appropriate candidates with adequate donor density. Pairing surgical intervention with ongoing finasteride is essential to preserve non-transplanted existing hair.
LLLT (laser therapy) as adjunct: Modest standalone evidence; contributes incrementally as part of a comprehensive approach.
Reversal potential: Moderate. Halting further loss is highly achievable. Partial regrowth in areas that have not undergone fibrosis is realistic. Full density recovery is not the appropriate target.
Ages 55 and Beyond: Stabilisation and Dignity
What Is Happening
In those who have not treated, Norwood 6–7 patterns are common. Scalp fibrosis limits follicular reactivation in areas of long-standing hair loss. Metabolic health — cardiovascular function, blood glucose regulation, nutrient absorption — has an increasing direct bearing on follicular function.
But the premise of this section is not resignation. It is recalibrated realism.
What Works
Finasteride: Primarily to halt further progression. PSA monitoring is important — finasteride reduces PSA by approximately 50%, which can mask prostate health concerns if not accounted for.
Hair transplant: Viable for patients with adequate donor zones and good overall health. A specialist consultation to assess donor density and scalp fibrosis extent is essential.
Scalp micropigmentation (SMP): A non-surgical cosmetic procedure that creates the visual impression of a closely shaved head with full density. For people at advanced Norwood stages, SMP produces significant quality-of-life improvements.
Keratin fibre concealers: An underrated daily tool. High-quality keratin fibres (Toppik, Nanogen) electrodynamically bond to existing hair shafts, creating the visual impression of density. They are not a treatment — they are a confidence tool, and they work.
Reversal potential: Lower in areas of established fibrosis and long-term dormancy. Stabilisation and aesthetic management are the realistic primary goals, with targeted regrowth in partially affected areas still possible.
A Note on the Psychology at Every Age
The research on hair loss and confidence is consistent: the impact is primarily mediated through perceived unattractiveness. But the same research consistently finds that this perception is significantly distorted. Partner attractiveness ratings rank hair density well below social confidence, posture, fitness, and communication style.
Working on what changes quickly — confidence, fitness, style — while the hair catches up at its own pace is not a compromise. It is the most practical path.
At every age, the act of having a protocol — of having made a considered decision to do something — changes the psychological relationship with the problem. Passive suffering and active management produce very different experiences of the same timeline.
Frequently Asked Questions
What is the Norwood scale? The Norwood–Hamilton scale is the standard classification system for male pattern baldness, ranging from Type 1 (no recession) to Type 7 (only a horseshoe band of hair remaining). It is primarily useful for tracking progression and calibrating treatment expectations, not for defining identity.
Does hair loss skip generations? The genetics of androgenetic alopecia are polygenic — inherited from multiple genes on multiple chromosomes, from both maternal and paternal lines. The common belief that you inherit hair loss from your mother’s father is a simplification. Look at both sides of your family for a more accurate predictor.
Is it ever truly too late to start treatment? For finasteride and minoxidil: there is no age at which starting provides zero benefit. The treatment primarily prevents further miniaturisation, which has value at any age. For surgical intervention, the limiting factors are donor density and health, not age per se.
How do I know if my follicles are still active? A trichoscopy examination by a dermatologist can identify whether follicles in thinning areas are producing vellus (fine, unpigmented) hairs — which means they are miniaturised but active and potentially responsive to treatment — or whether there is complete follicular loss in that area. This is the most clinically useful piece of information for setting realistic treatment expectations.